 "Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG")
Ahmedabad based Torrent Pharma has acquired two gynaecology products from Switzerland-based Novartis AG for an undisclosed amount. “The company has completed the acquisition of Regestrone and Pregachieve brands for India from global pharma player Novartis AG,” said Torrent Pharma yesterday in a press statement. These brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, peri & post- menopausal symptoms and infertility.
Women healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. Regestrone and Pregachieve will further fortify the hormone segment.
“The use of hormones among the gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare,” added the release.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%